Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
After Chasing Fame and Finding Darkness, Actress Tehya Johns Finds Light and Love at Homestead Heritage
-
Base Carbon Reports Third-Quarter 2024 Operating and Financial Results
-
Capstone Infrastructure Corporation Reports Third Quarter Results and Declares a Quarterly Dividend
-
NCLA Asks Supreme Court to Rope in Horseracing Authority’s Unconstitutional Executive Power
-
Zefiro Methane Corp. Announces Quarterly Earnings with Record Revenue of USD $10 Million and Record Gross Profit of USD $3.3 Million
-
UPDATE - Tevogen Founder Reflects on Importance of Preserving Shareholder Value While Navigating Growth as it Prepares to File Quarterly Financials
-
Lowell Farms Inc. Announces Unaudited Third Quarter 2024 Financial and Operational Results
-
The Metals Company Provides Third Quarter 2024 Corporate Update
-
Draganfly Announces Third Quarter Results for 2024
-
Consolidated Water Reports Third Quarter 2024 Operating Results
-
Toll Brothers Announces Grand Opening of Travisso - Verona Collection in Leander, Texas
-
First West addresses housing crisis through $250,000 community bond investment into sustainable co-operative housing development
-
Beneficient Reports Results for Second Quarter Fiscal 2025
-
Osteal Therapeutics Announces Positive 12-Month Results from the APEX Clinical Trial Program at the 2024 American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting
-
Cox Media Group Names SVP & Chief Sales Officer – CMG Television
-
United Community Banks, Inc. Announces Quarterly Cash Dividend on Common and Preferred Stock
-
Cox Media Group Names SVP & Chief Sales Officer – CMG Television
-
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
-
QuoteMedia Announces Financial Results for Q3 2024
-
Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results
-
Kadant Declares Cash Dividend
-
Fusion CBD Products Launches Wiggles & Paws
-
Precision Optics Receives Initial Production Order for Single-Use Ophthalmic Program
-
Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
-
Precision Optics Reports First Quarter Fiscal Year 2025 Financial Results
-
POET Technologies Reports Third Quarter 2024 Financial Results
-
Jewett-Cameron to Report Fiscal 2024 Full Year and Fourth Quarter Operational and Financial Results on November 20, 2024
-
Milestone Scientific Achieves 22% Increase in Revenue for the Third Quarter of 2024
-
Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update
-
The Metals Company Announces US$17.5 Million Registered Direct Offering of Common Shares and Class B Warrants
-
Fusion CBD Products Launches Wiggles & Paws
-
XWELL, Inc. Reports Third Quarter 2024 Results
-
Marker Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
-
Sysco Metro New York Donates 2,500 Turkeys to Feed Those in Need This Thanksgiving
-
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
-
Traws Pharma Provides Business Update and Reports Q3 2024 Financial Results
-
Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt
-
Enthusiast Gaming Achieves Profitability, Reports Q3 2024 Financial Results
-
Digital Brands Group Reports Third Quarter 2024 Financial Results
-
Xtreme One Entertainment Announces Third Quarter 2024 Financial Results
-
ProCap is Proud to Announce the Planning Launch of the Luminex Payment Gateway
-
Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform
-
FSI ANNOUNCES THIRD QUARTER, 2024 FINANCIAL RESULTS
-
Skyline Bankshares, Inc. Announces Third Quarter 2024 Results
-
Acutus Medical Reports Third Quarter and Year-To-Date 2024 Financial Results
-
Mandatory Notification of Trade by Primary Insider
-
LifeWallet Announces Third Quarter 2024 Financial Results
-
Super League Announces Third Quarter 2024 Financial Results
-
GRI Bio Reports Third Quarter 2024 Financial Results and Outlines Progress Towards Clinical Data Readout of GRI-0621 in Ongoing Phase 2a Study for Idiopathic Pulmonary Fibrosis
-
Jamf Announces Upcoming Conference Participation

